help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-129-6-2951
Endocrinology Vol. 129, No. 6 2951-2956
Copyright © 1991 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NESTLER, J. E.
Right arrow Articles by LARNER, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NESTLER, J. E.
Right arrow Articles by LARNER, J.

Insulin Mediators Are the Signal Transduction System Responsible for Insulin’s Actions on Human Placental Steroidogenesis*

JOHN E. NESTLER, GUILLERMO ROMERO, LAURA C. HUANG, CHENGGUI ZHANG and JOSEPH LARNER

Department of Medicine, Medical College of Virginia/Virginia Commonwealth University Richmond, Virginia 23298;
The Department of Pharmacology, University of Virginia Charlottesville, Virginia 22908

Address requests for reprints to: Dr. John E. Nestler, Division of Endocrinology and Metabolism, Medical College of Virginia, MCV Station, Box 111, Richmond, Virginia 23298β0111.

Abstract

To test the hypothesis that insulin mediators serve as the signal transduction system for insulin’s steroidogenic actions in human placental cytotrophoblasts, we examined the effects of two inositolglycan insulin mediators, the insulin pH 2.0 chiro-inositol mediator (IM-pH 2.0) and the insulin pH 1.3 myo-inositol mediator (IM-pH 1.3), on cytotrophoblastic steroidogenesis. When human cytotrophoblasts were incubated in medium supplemented with androstenedione for 24 h, treatment with IM-pH 2.0 or IM-pH 1.3 suppressed aromatase activity by 15% (P < 0.05) and 49% (P < 0.05), respectively, compared to insulin, which suppressed aromatase activity by 21% (P < 0.05). When cytotrophoblasts were incubated in medium supplemented with pregnenolone for 24 h, treatment with IM-pH 2.0 or IM-pH 1.3 stimulated 3β-hydroxysteroid dehydrogenase (3j8HSD) activity by 145% (P < 0.05) and 168% (P < 0.05), respectively, compared to insulin, which stimulated 3βHSD activity by 63% (P < 0.05). Suppression of aromatase activity and stimulation of 3βHSD activity by inositolglycan mediators were both concentration dependent. Moreover, preincubation of cytotrophoblasts with the antiinositolglycan antibody {alpha}IGP completely abolished insulin’s ability to either inhibit aromatase or stimulate 3βHSD activity. These results indicate that insulin mediators mimic insulin’s effects on cytotrophoblastic aromatase and 3βHSD activities and suggest that inositolglycan mediators are the signal transduction mechanism responsible for insulin’s regulation of human placental steroid hormone biosynthesis. (Endocrinology 129: 2951β2956, 1991)

Footnotes

* This work was supported by the Diabetes Research and Education Foundation, a research award from the Virginia Affiliate of the American Diabetes Association, and the Thomas F. and Kate Miller Jeffress Memorial Trust; other support was received from NIH Grant DK-14334 and Diabetes Endocrinology Research Center Grant NIH-DK-38942.

Received June 19, 1991.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. McLean, S. Kunjara, A. L. Greenbaum, K. Gumaa, J. Lopez-Prados, M. Martin-Lomas, and T. W. Rademacher
Reciprocal Control of Pyruvate Dehydrogenase Kinase and Phosphatase by Inositol Phosphoglycans: DYNAMIC STATE SET BY "PUSH-PULL" SYSTEM
J. Biol. Chem., November 28, 2008; 283(48): 33428 - 33436.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. J. Jakubowicz, M. Seppälä, S. Jakubowicz, O. Rodriguez-Armas, A. Rivas-Santiago, H. Koistinen, R. Koistinen, and J. E. Nestler
Insulin Reduction with Metformin Increases Luteal Phase Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein 1 Concentrations and Enhances Uterine Vascularity and Blood Flow in the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1126 - 1133.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. E. Nestler, D. J. Jakubowicz, A. Falcon de Vargas, C. Brik, N. Quintero, and F. Medina
Insulin Stimulates Testosterone Biosynthesis by Human Thecal Cells from Women with Polycystic Ovary Syndrome by Activating Its Own Receptor and Using Inositolglycan Mediators as the Signal Transduction System
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2001 - 2005.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society